ADRIANO & ASSOCIATES
63
Betreute Anmeldungen
Technische BereichePatente
Biotechnologie34
Pharmazeutika12
Organische Feinchemie5
Grundsätzliche Werkstoffchemie3
Medizinische Technologie3

Heimatländer der Klienten

Zusammenfassung

ADRIANO & ASSOCIATES ist besonders erfahren in den Technologien „Biotechnologie“ und „Pharmazeutika“. 75% aller Patente wurden im Bereich „(Bio-)Chemie“ betreut. Die wichtigsten Klienten sind „THE REGENTS OF THE UNIVERSITY OF CALIFORNIA“ und „EMORY UNIVERSITY“. Besonders viele Patentanmeldungen wurden in den Jahren 1997 und 2015 betreut. Die Klienten stammen oftmals aus USA.

Patente nach Jahren

Patente nach Bereichen

2
Patentanmeldungen
4
Patentanmeldungen
47
Patentanmeldungen
1
Patentanmeldungen
2
Patentanmeldungen

Patente nach Anmeldern

RangNameLandPatente
1THE REGENTS OF THE UNIVERSITY OF CALIFORNIAUSA34
2EMORY UNIVERSITYPolen6
3BRISTOL-MYERS SQUIBB COMPANYUSA4
4BULLET BIOTECHNOLOGY, INC.USA2
5GEORGIA TECH RESEARCH CORPORATIONUSA2
6IMPAX LABORATORIES, INC.USA2
7LORIA, EMILEFrankreich2
8NICOLAOU, MICHALISUSA2
9TERRASSE, GAETANFrankreich2
10THE REGENTS OF THE UNIVERSITY OF CALIFORNIA OFFICE OF THE PRESIDENTBrasilien2
11TREHIN, YVESFrankreich2
12ACCUWAVE CORPORATIONUSA1
13BIONETWORKS GMBHUSA1
14CALIFORNIA INSTITUTE OF TECHNOLOGYUSA1
15COPPEL, ROSSUSA1
16FAN, ANNABELUSA1
17GERSHWIN, ERICAustralien1
18INDUS PHARMACEUTICALS, INC.USA1
19LANDRY, DONALD, W.USA1
20LEUNG, PATRICKUSA1
21LIU, BINChina1
22NEOMECS INCORPORATEDJapan1
23OLIVER, JUAN, A.USA1
24ORECK, ADAM, H.USA1
25THE BOARD OF TRUSTEES OF THE LELAND STANDFORD JUNIOR UNIVERSITYUSA1

Letzte Anmeldungen

PublikationsnummerTitelPatentanmelderJahr
WO2016018481NETWORK BASED STRATIFICATION OF TUMOR MUTATIONSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
2016
WO2015200920CULTURED MAMMALIAN LIMBAL STEM CELLS, METHODS FOR GENERATING THE SAME, AND USES THEREOFTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
2015
WO2015120203METHODS OF TREATING MILD BRAIN INJURYTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
2015
WO2015089114SPECIFIC VIRUS-LIKE PARTICLE-CPG OLIGONUCLEOTIDE VACCINES AND USES THEREOFBULLET BIOTECHNOLOGY, INC.
2015
WO2015054302MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOFIMPAX LABORATORIES, INC.
2015
WO2015054526METHODS OF MAMMALIAN RETINAL STEM CELL PRODUCTION AND APPLICATIONSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
2015
WO2014145932SPECIFIC MULTIVALENT VIRUS-LIKE PARTICLE VACCINES AND USES THEREOFBULLET BIOTECHNOLOGY, INC.
THE BOARD OF TRUSTEES OF THE LELAND STANDFORD JUNIOR UNIVERSITY
2014
WO2014075083METHODS FOR PREDICTING AGE AND IDENTIFYING AGENTS THAT INDUCE OR INHIBIT PREMATURE AGINGBIONETWORKS GMBH
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
2014
WO2014022717METHODS FOR ORGANIZING THE DISINFECTION OF ONE OR MORE ITEMS CONTAMINATED WITH BIOLOGICAL AGENTSTHE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
2014
WO2013163455A DRUG SCREENING PLATFORM FOR RETT SYNDROMETHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
2013
WO2013151638NOVEL COMPOSITIONS OF COMBINATIONS OF NON-COVALENT DNA BINDING AGENTS AND ANTI-CANCER AND/OR ANTI-INFLAMMATORY AGENTS AND THEIR USE IN DISEASE TREATMENTINDUS PHARMACEUTICALS, INC.
2013
WO2013149259METHOD FOR PROMOTING LIPOLYSIS AND OXIDATION IN LIVER AND ADIPOSE TISSUE USING CATESTATINTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
2013
WO2012106662NEW AGENTS TO TREAT/PREVENT AMOEBIASISTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
2012
WO2012106665DISIALYLLACTO-N-TETRAOSE (DSLNT) OR VARIANTS, ISOMERS, ANALOGS AND DERIVATIVES THEREOF TO PREVENT OR INHIBIT BOWEL DISEASETHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
2012
WO2012061828NEURONAL SPECIFIC TARGETING OF CAVEOLIN EXPRESSION TO RESTORE SYNAPTIC SIGNALING AND IMPROVE COGNITIVE FUNCTION IN THE NEURODEGENERATIVE BRAIN AND MOTOR FUNCTION IN SPINAL CORDTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
2012
WO2012034101EXPANDABLE CELL SOURCE OF NEURONAL STEM CELL POPULATIONS AND METHODS FOR OBTAINING AND USING THEMTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
2012
WO2012015979HMGB1-DERIVED PEPTIDES ENHANCE IMMUNE RESPONSE TO ANTIGENSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
2012
WO2011163636COMPOUNDS AND USES THEREOF IN MODULATING LEVELS OF VARIOUS AMYLOID BETA PEPTIDE ALLOFORMSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
2011
WO2011140397STEM CELL DEFINED MEDIA FOR XENO-FREE AND FEEDER FREE CONDITIONS AND USES THEREOFTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA OFFICE OF THE PRESIDENT
2011
WO2010028306ANTIBODIES WITH MANNOSE BINDING LECTIN EFFECTOR FUNCTION FOR INHIBITING PATHOLOGIC INFLAMMATORY CONDITIONSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA OFFICE OF THE PRESIDENT
2010
WO2009085306CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND USES THEREOFIMPAX LABORATORIES, INC.
2009
WO2009017842DETACHABLE LUGGAGE FOR BABY STROLLERSFAN, ANNABEL
2009
WO2008127532NOVEL STRATEGIES FOR DELIVERY OF ACTIVE AGENTS USING MICELLES AND PARTICLESGEORGIA TECH RESEARCH CORPORATION
EMORY UNIVERSITY
2008
WO2008100539TREATMENT OF COPD, GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD), FOOD ALLERGIES AND OTHER GASTROINTESTINAL CONDITIONS AND DISORDERS AMELIORATED BY PROPER HISTAMINE MANAGEMENT USING A COMBINATION OF HISTIDINE DECARBOXYLASE INHIBITORS, LRA DRUGS, ANTI-H1 AND/OR TERRASSE, GAETAN
LORIA, EMILE
TREHIN, YVES
NICOLAOU, MICHALIS
2008
WO2007117704PURE ISOMERS OF TRITOQUALINELORIA, EMILE
TREHIN, YVES
NICOLAOU, MICHALIS
TERRASSE, GAETAN
2007